sb 203580 has been researched along with Corneal Injuries in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Koizumi, N; Nakahara, M; Nakano, S; Okumura, N | 1 |
Askar, I; Chan, D; Flanagan, JG; Guo, X; Lam, S; Livne-Bar, I; Nahirnyj, A; Sivak, JM | 1 |
2 other study(ies) available for sb 203580 and Corneal Injuries
Article | Year |
---|---|
Effect of a p38 Mitogen-Activated Protein Kinase Inhibitor on Corneal Endothelial Cell Proliferation.
Topics: Animals; Blotting, Western; Cell Proliferation; Cell- and Tissue-Based Therapy; Cells, Cultured; Corneal Injuries; Disease Models, Animal; Endothelial Cells; Endothelium, Corneal; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Rabbits | 2018 |
Pharmacologic inhibition of reactive gliosis blocks TNF-α-mediated neuronal apoptosis.
Topics: Animals; Apoptosis; Astrocytes; Corneal Injuries; Disease Models, Animal; Gliosis; Imidazoles; Intermediate Filaments; Male; Mice, Inbred C57BL; Neuroglia; p38 Mitogen-Activated Protein Kinases; Polymerization; Pyridines; Retinal Neurons; Tumor Necrosis Factor-alpha; Withanolides | 2016 |